Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L

Penn Center for Molecular Discovery, University of Pennsylvania, 1024 Vagelos Laboratories, Philadelphia, PA 19104-6383, USA.
Molecular pharmacology (Impact Factor: 4.12). 08/2008; 74(1):34-41. DOI: 10.1124/mol.108.046219
Source: PubMed

ABSTRACT A novel small molecule thiocarbazate (PubChem SID 26681509), a potent inhibitor of human cathepsin L (EC with an IC(50) of 56 nM, was developed after a 57,821-compound screen of the National Institutes of Health Molecular Libraries Small Molecule Repository. After a 4-h preincubation with cathepsin L, this compound became even more potent, demonstrating an IC(50) of 1.0 nM. The thiocarbazate was determined to be a slow-binding and slowly reversible competitive inhibitor. Through a transient kinetic analysis for single-step reversibility, inhibition rate constants were k(on) = 24,000 M(-1)s(-1) and k(off) = 2.2 x 10(-5) s(-1) (K(i) = 0.89 nM). Molecular docking studies were undertaken using the experimentally derived X-ray crystal structure of papain/CLIK-148 (1cvz. pdb). These studies revealed critical hydrogen bonding patterns of the thiocarbazate with key active site residues in papain. The thiocarbazate displayed 7- to 151-fold greater selectivity toward cathepsin L than papain and cathepsins B, K, V, and S with no activity against cathepsin G. The inhibitor demonstrated a lack of toxicity in human aortic endothelial cells and zebrafish. In addition, the thiocarbazate inhibited in vitro propagation of malaria parasite Plasmodium falciparum with an IC(50) of 15.4 microM and inhibited Leishmania major with an IC(50) of 12.5 microM.


Available from: Elizabeth R Sharlow, May 26, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The interactive manipulation of complicated environments poses a real challenge since it involves the simultaneous management of several heterogeneous constraints. For instance, molecular design requires the simultaneous control of several connected kinematic structures, with strong physical and chemical interactions, to provide the relevant conformation and docking solutions. This paper investigates two working strategies for carrying out closely coupled manipulations in such environments. We present an experimental study which compares bimanual and collaborative configurations. For both strategies, we provide users with the same number of resources, such as the same visualization system and the same number of manipulation tools. The performances are better in the collaborative configuration for the simultaneous management of several constraints and the manipulation of distant regions. However, this working strategy involves a strong communication flow to coordinate the actions. The performances are better in the bimanual configuration when the tasks involve a limited working space and a low level of constraints.
    International Journal of Human-Computer Studies 01/2013; DOI:10.1016/j.ijhcs.2013.12.002 · 1.17 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The use of proteinases as targets to develop novel chemotherapies against Leishmania spp. infections is a very promising strategy. Based on a previous study by Goyal et al. [J Mol Model (2014) 20:2099], we discuss herein the idea that only a combined treatment with distinct proteinase inhibitors would be an effective antileishmanial therapy.
    Journal of Molecular Modeling 10/2014; 20(10):2465. DOI:10.1007/s00894-014-2465-4 · 1.87 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Enzyme kinetics studies reported in the literature showed that human liver Cathepsin L is active only at lysosomal acidic pH values, while biochemical studies in living cells showed that the enzyme works even at neutral pH values (in a condition compatible with the extracellular compartment). Such an apparent ambiguity highlighted the need of analysing in depth the kinetics of ~29 kDa Cathepsin L, which is the form commonly used in experiments. The stability and catalytic activity of this enzyme were investigated at different pH values, reducing and non-reducing environments, presence of copper, iron and zinc ions, and presence of the natural modulator/inhibitor cystatin B. Our experiments showed that ~29 kDa human liver Cathepsin L is stable and catalytically functional even at neutral pH values and under non-reducing conditions, which simulate the extracellular compartment. Under these conditions, Cathepsin L was also proved to interact with cystatin B, being also modulated by physiological concentrations of Cu(++) , Fe(++) and Zn(++) . This paper suppose an advance in the comprehension of the catalytic properties of human liver Cathepsin L, its implications in different physiological processes and its potential use within a drug screening program in which agents acting extracellularly are being considered. This article is protected by copyright. All rights reserved.
    Chemical Biology &amp Drug Design 06/2014; DOI:10.1111/cbdd.12357 · 2.51 Impact Factor